WO2012173383A3 - 크립토탄시논을 유효성분으로 함유하는 피부 외용제 조성물 - Google Patents
크립토탄시논을 유효성분으로 함유하는 피부 외용제 조성물 Download PDFInfo
- Publication number
- WO2012173383A3 WO2012173383A3 PCT/KR2012/004647 KR2012004647W WO2012173383A3 WO 2012173383 A3 WO2012173383 A3 WO 2012173383A3 KR 2012004647 W KR2012004647 W KR 2012004647W WO 2012173383 A3 WO2012173383 A3 WO 2012173383A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- skin
- active ingredient
- external use
- use containing
- skin composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/513—Organic macromolecular compounds; Dendrimers
- A61K9/5138—Organic macromolecular compounds; Dendrimers obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Biomedical Technology (AREA)
- Nanotechnology (AREA)
- Optics & Photonics (AREA)
- Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Cosmetics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
본 발명은 크립토탄시논(Cryptotanshinone), 그의 이성질체, 그의 전구체, 그의 염, 그의 수화물 또는 그의 용매화물을 유효성분으로 함유하는 피부 외용제 조성물을 제공한다. 본 발명의 조성물은 피부 노화 억제, 피부 주름 개선, 피부 미백, 피부 보습, 아토피 개선, 피부 혈색 개선 및 피부 투명도 개선 효과가 있다.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2011-0058903 | 2011-06-17 | ||
KR20110058903A KR101481208B1 (ko) | 2011-06-17 | 2011-06-17 | 크립토탄시논을 유효성분으로 함유하는 피부 외용제 조성물 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2012173383A2 WO2012173383A2 (ko) | 2012-12-20 |
WO2012173383A3 true WO2012173383A3 (ko) | 2013-03-14 |
Family
ID=47357593
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/KR2012/004647 WO2012173383A2 (ko) | 2011-06-17 | 2012-06-13 | 크립토탄시논을 유효성분으로 함유하는 피부 외용제 조성물 |
Country Status (2)
Country | Link |
---|---|
KR (1) | KR101481208B1 (ko) |
WO (1) | WO2012173383A2 (ko) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102001048B1 (ko) * | 2013-08-14 | 2019-07-17 | 주식회사 엘지생활건강 | 피부 재생, 주름개선, 항산화 및 피부 미백용 조성물 |
CN104473784B (zh) * | 2014-11-24 | 2017-08-22 | 广州神采化妆品有限公司 | 一种出油按摩膏及其制备方法 |
CN111420023B (zh) * | 2020-04-30 | 2024-03-15 | 广州市红十字会医院(暨南大学医学院附属广州红十字会医院) | 含i型胶原和透明质酸的复合物及制备和用途 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20050071355A (ko) * | 2003-12-30 | 2005-07-07 | 주식회사 케이티앤지 | 대사활성을 촉진시키는 탄시논 유도체를 유효성분으로함유하는 비만 및 대사증후군 치료제 |
US20060045896A1 (en) * | 2004-08-31 | 2006-03-02 | Tracie Martyn International, Llc | Topical compositions comprising benfotiamine and pyridoxamine |
KR100861186B1 (ko) * | 2001-03-26 | 2008-09-30 | 주식회사 엘지생활건강 | 크립토탄시논을 함유하는 여드름 예방 및 치료용 화장료 |
WO2009050451A1 (en) * | 2007-10-15 | 2009-04-23 | Botanic Century (Beijing) Co. Ltd | Antibacterial composition comprising salvia extracts |
-
2011
- 2011-06-17 KR KR20110058903A patent/KR101481208B1/ko active IP Right Grant
-
2012
- 2012-06-13 WO PCT/KR2012/004647 patent/WO2012173383A2/ko active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100861186B1 (ko) * | 2001-03-26 | 2008-09-30 | 주식회사 엘지생활건강 | 크립토탄시논을 함유하는 여드름 예방 및 치료용 화장료 |
KR20050071355A (ko) * | 2003-12-30 | 2005-07-07 | 주식회사 케이티앤지 | 대사활성을 촉진시키는 탄시논 유도체를 유효성분으로함유하는 비만 및 대사증후군 치료제 |
US20060045896A1 (en) * | 2004-08-31 | 2006-03-02 | Tracie Martyn International, Llc | Topical compositions comprising benfotiamine and pyridoxamine |
WO2009050451A1 (en) * | 2007-10-15 | 2009-04-23 | Botanic Century (Beijing) Co. Ltd | Antibacterial composition comprising salvia extracts |
Also Published As
Publication number | Publication date |
---|---|
KR101481208B1 (ko) | 2015-01-12 |
KR20120139223A (ko) | 2012-12-27 |
WO2012173383A2 (ko) | 2012-12-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3199036A4 (en) | Composition, containing tyndallized lactobacillus dead cells as active ingredient, for skin moisturizing or wrinkle improvement | |
WO2013158851A3 (en) | Improving skin appearance with increase in skin chroma | |
EP3060041A4 (en) | Prostacyclin compounds, compositions and methods of use thereof | |
EP2827869A4 (en) | COMPOSITIONS AND METHODS FOR IMPROVING THE THERAPEUTIC BENEFIT OF INDIRUBIN AND ITS ANALOGUES INCLUDING MESOINDIGO | |
HK1186965A1 (zh) | 用於美白和改善皮膚彈性的化妝品組合物 | |
NZ628294A (en) | Compositions and methods of use of phorbol esters for the treatment of stroke | |
HK1178465A1 (en) | Composition for improving condition of skin | |
EP2654745A4 (en) | COMPOSITION FOR TREATING SKIN CONDITIONS OF THE SKIN | |
WO2013098416A3 (fr) | Composes anti-douleur | |
EP3354254A4 (en) | SKIN-SHELLING COMPOSITION WITH BETA-MANGOSTINE AS AN ACTIVE SUBSTANCE | |
WO2013034855A3 (fr) | Association de carraghénane et de c-glycoside et leurs utilisations | |
WO2013002518A3 (ko) | 화장료 조성물을 포함하는 피부 미용 키트 및 도포방법 | |
WO2012076109A3 (de) | 2-pyrone | |
EP2994134A4 (en) | Methods of administering dantrolene for the acute treatment of cardiac arrhythmias | |
MX2014009750A (es) | Composiciones antifungicas para el tratamiento de piel y uñas. | |
EP3052078A4 (en) | Methods and compositions for improving the appearance of skin | |
HK1185290A1 (zh) | 改善面部毛孔的外觀的組合物和方法 | |
WO2012173382A3 (ko) | 탄시논ⅱa를 유효성분으로 함유하는 피부 외용제 조성물 | |
MX2015012580A (es) | El uso de sdf-1 para atenuar la formacion de cicatrices. | |
WO2012128971A3 (en) | Topical acyl glutathione formulations | |
WO2012104332A3 (de) | Desodorierender hautfilm | |
WO2013012197A3 (ko) | 허니부쉬 추출물 또는 이의 발효액을 유효성분으로 함유하는 피부 주름 예방 또는 개선용 조성물 | |
EP3061448A4 (en) | Composition containing eugenol as active ingredient for preventing or treating atopic dermatitis | |
EP2533752B8 (de) | Zubereitungen zur stabilisierung / aufbau der textur lebender gewebe wie haut, und deren anwendungen | |
WO2012173383A3 (ko) | 크립토탄시논을 유효성분으로 함유하는 피부 외용제 조성물 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 12800469 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
32PN | Ep: public notification in the ep bulletin as address of the adressee cannot be established |
Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205A DATED 07/04/2014) |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 12800469 Country of ref document: EP Kind code of ref document: A2 |